TreeWAS – Variant ID: rs10904908

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H11 Other disorders of conjunctiva	0.000	0.946	0.054
H11.3 Conjunctival haemorrhage	0.000	0.946	0.054
H11.0 Pterygium	0.000	0.948	0.052
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.953	0.047
H11.1 Conjunctival degenerations and deposits	0.000	0.955	0.045
H11.8 Other specified disorders of conjunctiva	0.000	0.955	0.045
H11.9 Disorder of conjunctiva, unspecified	0.000	0.962	0.038
H11.2 Conjunctival scars	0.000	0.965	0.034
H10-H13 Disorders of conjunctiva	0.000	0.967	0.033
H10 Conjunctivitis	0.000	0.972	0.028
L91.8 Other hypertrophic disorders of skin	0.026	0.974	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.000	0.974	0.025
H10.9 Conjunctivitis, unspecified	0.000	0.975	0.025
L91 Hypertrophic disorders of skin	0.022	0.978	0.000
L91.0 Keloid scar	0.022	0.978	0.000
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.000	0.980	0.020
H10.8 Other conjunctivitis	0.000	0.980	0.020
H10.5 Blepharoconjunctivitis	0.000	0.980	0.020
H10.2 Other acute conjunctivitis	0.000	0.980	0.020
H10.1 Acute atopic conjunctivitis	0.000	0.980	0.020
K04.8 Radicular cyst	0.000	0.980	0.020
H10.3 Acute conjunctivitis, unspecified	0.000	0.980	0.019
H10.4 Chronic conjunctivitis	0.000	0.981	0.019
H13.3 Ocular pemphigoid	0.000	0.981	0.019
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.000	0.981	0.018
H13.2 Conjunctivitis in other diseases classified elsewhere	0.000	0.981	0.018
H13.0 Filarial infection of conjunctiva	0.000	0.981	0.018
H10.0 Mucopurulent conjunctivitis	0.000	0.981	0.018
L91.9 Hypertrophic disorder of skin, unspecified	0.017	0.983	0.000
M93.9 Osteochondropathy, unspecified	0.011	0.989	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.010	0.990	0.000
M93 Other osteochondropathies	0.010	0.990	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.009	0.991	0.000
M91-M94 Chondropathies	0.009	0.991	0.000
M94.8 Other specified disorders of cartilage	0.008	0.992	0.000
M94 Other disorders of cartilage	0.008	0.992	0.000
M92 Other juvenile osteochondrosis	0.008	0.992	0.000
M92.7 Juvenile osteochondrosis of metatarsus	0.008	0.992	0.000
M93.8 Other specified osteochondropathies	0.007	0.993	0.000
M93.2 Osteochondritis dissecans	0.007	0.993	0.000
M93.1 Kienbock's disease of adults	0.007	0.993	0.000
M93.0 Slipped upper femoral epiphysis (nontraumatic)	0.007	0.993	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.007	0.993	0.000
M94.9 Disorder of cartilage, unspecified	0.007	0.993	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.007	0.993	0.000
M92.6 Juvenile osteochondrosis of tarsus	0.007	0.993	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.006	0.994	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.006	0.994	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.006	0.994	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.006	0.994	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.006	0.994	0.000
M94.3 Chondrolysis	0.006	0.994	0.000
M94.1 Relapsing polychondritis	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.006	0.994	0.000
M92.5 Juvenile osteochondrosis of tibia and fibula	0.006	0.994	0.000
M92.1 Juvenile osteochondrosis of radius and ulna	0.006	0.994	0.000
M92.9 Juvenile osteochondrosis, unspecified	0.006	0.994	0.000
M92.8 Other specified juvenile osteochondrosis	0.006	0.994	0.000
M92.4 Juvenile osteochondrosis of patella	0.006	0.994	0.000
M92.3 Other juvenile osteochondrosis of upper limb	0.006	0.994	0.000
M92.2 Juvenile osteochondrosis of hand	0.006	0.994	0.000
M92.0 Juvenile osteochondrosis of humerus	0.006	0.994	0.000
M94.88 Other specified disorders of cartilage (Other)	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.006	0.994	0.000
M91 Juvenile osteochondrosis of hip and pelvis	0.006	0.994	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.006	0.994	0.000
K12.3 Oral mucositis (ulcerative)	0.000	0.994	0.006
M94.2 Chondromalacia	0.006	0.994	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.006	0.994	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.006	0.994	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.006	0.994	0.000
J33.0 Polyp of nasal cavity	0.006	0.994	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.005	0.994	0.000
T42.3 Barbiturates	0.005	0.994	0.000
M93.26 Osteochondritis dissecans knee	0.005	0.995	0.000
M93.86 Other specified osteochondropathies, lower leg	0.005	0.995	0.000
T79.3 Post-traumatic wound infection, not elsewhere classified	0.005	0.995	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.005	0.995	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.005	0.995	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.995	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.995	0.000
T79 Certain early complications of trauma, not elsewhere classified	0.005	0.995	0.000
T42.1 Iminostilbenes	0.005	0.995	0.000
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.005	0.995	0.000
M94.98 Disorder of cartilage, unspecified (Other)	0.005	0.995	0.000
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.005	0.995	0.000
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
M94.94 Disorder of cartilage, unspecified (Hand)	0.005	0.995	0.000
M94.93 Disorder of cartilage, unspecified (Forearm)	0.005	0.995	0.000
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.005	0.995	0.000
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.005	0.995	0.000
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.005	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
T79.8 Other early complications of trauma	0.005	0.995	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.995	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
M94.19 Relapsing polychondritis (Site unspecified)	0.005	0.995	0.000
M94.18 Relapsing polychondritis (Other)	0.005	0.995	0.000
M94.17 Relapsing polychondritis (Ankle and foot)	0.005	0.995	0.000
M94.16 Relapsing polychondritis (Lower leg)	0.005	0.995	0.000
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.005	0.995	0.000
M94.14 Relapsing polychondritis (Hand)	0.005	0.995	0.000
M94.13 Relapsing polychondritis (Forearm)	0.005	0.995	0.000
M94.12 Relapsing polychondritis (Upper arm)	0.005	0.995	0.000
M94.11 Relapsing polychondritis (Shoulder region)	0.005	0.995	0.000
M94.10 Relapsing polychondritis (Multiple sites)	0.005	0.995	0.000
M94.39 Chondrolysis (Site unspecified)	0.005	0.995	0.000
M94.38 Chondrolysis (Other)	0.005	0.995	0.000
M94.37 Chondrolysis (Ankle and foot)	0.005	0.995	0.000
M94.36 Chondrolysis (Lower leg)	0.005	0.995	0.000
M94.35 Chondrolysis (Pelvic region and thigh)	0.005	0.995	0.000
M94.34 Chondrolysis (Hand)	0.005	0.995	0.000
M94.33 Chondrolysis (Forearm)	0.005	0.995	0.000
M94.32 Chondrolysis (Upper arm)	0.005	0.995	0.000
M94.31 Chondrolysis (Shoulder region)	0.005	0.995	0.000
M94.30 Chondrolysis (Multiple sites)	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.005	0.995	0.000
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.005	0.995	0.000
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.005	0.995	0.000
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.005	0.995	0.000
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.005	0.995	0.000
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.005	0.995	0.000
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.005	0.995	0.000
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.005	0.995	0.000
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T79.7 Traumatic subcutaneous emphysema	0.005	0.995	0.000
M92.10 Juvenile osteochondrosis of radius and ulna, unspecified arm	0.004	0.995	0.000
M92.51 Juvenile osteochondrosis of tibia and fibula, right leg	0.004	0.995	0.000
M92.50 Juvenile osteochondrosis of tibia and fibula, unspecified leg	0.004	0.995	0.000
T79.6 Traumatic ischaemia of muscle	0.005	0.995	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.000	0.995	0.005
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.004	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
E23.0 Hypopituitarism	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.004	0.995	0.000
T38.7 Androgens and anabolic congeners	0.004	0.995	0.000
T38.5 Other oestrogens and progestogens	0.004	0.995	0.000
T38.4 Oral contraceptives	0.004	0.995	0.000
T38.2 Antithyroid drugs	0.004	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.995	0.000
E87.0 Hyperosmolality and hypernatraemia	0.000	0.995	0.005
T38.1 Thyroid hormones and substitutes	0.004	0.995	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.995	0.000
M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified	0.004	0.996	0.000
M91.8 Other juvenile osteochondrosis of hip and pelvis	0.004	0.996	0.000
M91.3 Pseudocoxalgia	0.004	0.996	0.000
M91.0 Juvenile osteochondrosis of pelvis	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
M94.29 Chondromalacia (Site unspecified)	0.004	0.996	0.000
M94.28 Chondromalacia (Other)	0.004	0.996	0.000
M94.27 Chondromalacia (Ankle and foot)	0.004	0.996	0.000
M94.25 Chondromalacia (Pelvic region and thigh)	0.004	0.996	0.000
M94.24 Chondromalacia (Hand)	0.004	0.996	0.000
M94.23 Chondromalacia (Forearm)	0.004	0.996	0.000
M94.22 Chondromalacia (Upper arm)	0.004	0.996	0.000
M94.21 Chondromalacia (Shoulder region)	0.004	0.996	0.000
M94.20 Chondromalacia (Multiple sites)	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T39.0 Salicylates	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
M91.1 Juvenile osteochondrosis of head of femur [Legg-Calve-Perthes]	0.004	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.004	0.996	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.004	0.996	0.000
T79.5 Traumatic anuria	0.004	0.996	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.004	0.996	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.004	0.996	0.000
T79.9 Unspecified early complication of trauma	0.004	0.996	0.000
T79.4 Traumatic shock	0.004	0.996	0.000
T79.2 Traumatic secondary and recurrent haemorrhage	0.004	0.996	0.000
T79.1 Fat embolism (traumatic)	0.004	0.996	0.000
T79.0 Air embolism (traumatic)	0.004	0.996	0.000
M91.2 Coxa plana	0.004	0.996	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.004	0.996	0.000
T50.5 Appetite depressants	0.004	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
T50.8 Diagnostic agents	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
M94.26 Chondromalacia (Lower leg)	0.004	0.996	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.996	0.000
T46.7 Peripheral vasodilators	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
T48.4 Expectorants	0.004	0.996	0.000
T48.3 Antitussives	0.004	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
T48.0 Oxytocic drugs	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.004	0.996	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.000	0.996	0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.004	0.996	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
E23 Hypofunction and other disorders of pituitary gland	0.004	0.996	0.000
Z04.3 Examination and observation following other accident	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.003	0.996	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.003	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
R90.0 Intracranial space-occupying lesion	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.996	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.003	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.996	0.000
T37.5 Antiviral drugs	0.003	0.996	0.000
T37.4 Anthelminthics	0.003	0.996	0.000
T37.3 Other antiprotozoal drugs	0.003	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.996	0.000
T37.1 Antimycobacterial drugs	0.003	0.996	0.000
T37.0 Sulphonamides	0.003	0.996	0.000
T49.9 Topical agent, unspecified	0.003	0.996	0.000
T49.8 Other topical agents	0.003	0.996	0.000
T49.7 Dental drugs, topically applied	0.003	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.996	0.000
T49.2 Local astringents and local detergents	0.003	0.996	0.000
T49.1 Antipruritics	0.003	0.996	0.000
M91.09 Juvenile osteochondrosis of pelvis-Site unspec	0.003	0.996	0.000
M91.08 Juvenile osteochondrosis of pelvis-Other	0.003	0.996	0.000
M91.07 Juvenile osteochondrosis of pelvis-Ankle/Foot	0.003	0.996	0.000
M91.06 Juvenile osteochondrosis of pelvis-Lower Leg	0.003	0.996	0.000
M91.05 Juvenile osteochondrosis of pelvis-Pelvic/Thigh	0.003	0.996	0.000
M91.04 Juvenile osteochondrosis of pelvis-Hand	0.003	0.996	0.000
M91.03 Juvenile osteochondrosis of pelvis-Forearm	0.003	0.996	0.000
M91.02 Juvenile osteochondrosis of pelvis-Upper arm	0.003	0.996	0.000
M91.01 Juvenile osteochondrosis of pelvis-Shldr region	0.003	0.996	0.000
M91.00 Juvenile osteochondrosis of pelvis-Mult sites	0.003	0.996	0.000
M91.39 Pseudocoxalgia-Site unspec	0.003	0.996	0.000
M91.38 Pseudocoxalgia-Other	0.003	0.996	0.000
M91.37 Pseudocoxalgia-Ankle/Foot	0.003	0.996	0.000
M91.36 Pseudocoxalgia-Lower Leg	0.003	0.996	0.000
M91.35 Pseudocoxalgia-Pelvic/Thigh	0.003	0.996	0.000
M91.34 Pseudocoxalgia-Hand	0.003	0.996	0.000
M91.33 Pseudocoxalgia-Forearm	0.003	0.996	0.000
M91.32 Pseudocoxalgia-Upper arm	0.003	0.996	0.000
M91.31 Pseudocoxalgia-Shldr region	0.003	0.996	0.000
M91.30 Pseudocoxalgia-Mult sites	0.003	0.996	0.000
M91.89 Other juvenile osteochondrosis of hip and pelvis-Site unspe	0.003	0.996	0.000
M91.88 Other juvenile osteochondrosis of hip and pelvis-Other	0.003	0.996	0.000
M91.87 Other juvenile osteochondrosis of hip and pelvis-Ankle/Foot	0.003	0.996	0.000
M91.86 Other juvenile osteochondrosis of hip and pelvis-Lower Leg	0.003	0.996	0.000
M91.85 Other juvenile osteochondrosis of hip and pelvis-Pelvic/Thi	0.003	0.996	0.000
M91.84 Other juvenile osteochondrosis of hip and pelvis-Hand	0.003	0.996	0.000
M91.83 Other juvenile osteochondrosis of hip and pelvis-Forearm	0.003	0.996	0.000
M91.82 Other juvenile osteochondrosis of hip and pelvis-Upper arm	0.003	0.996	0.000
M91.81 Other juvenile osteochondrosis of hip and pelvis-Shldr regi	0.003	0.996	0.000
M91.80 Other juvenile osteochondrosis of hip and pelvis (Multiple sites)	0.003	0.996	0.000
M91.99 Juvenile osteochondrosis of hip and pelvis, unspecified-Sit	0.003	0.996	0.000
M91.98 Juvenile osteochondrosis of hip and pelvis, unspecified-Oth	0.003	0.996	0.000
M91.97 Juvenile osteochondrosis of hip and pelvis, unspecified-Ank	0.003	0.996	0.000
M91.96 Juvenile osteochondrosis of hip and pelvis, unspecified-Low	0.003	0.996	0.000
M91.95 Juvenile osteochondrosis of hip and pelvis, unspecified-Pel	0.003	0.996	0.000
M91.94 Juvenile osteochondrosis of hip and pelvis, unspecified-Han	0.003	0.996	0.000
M91.93 Juvenile osteochondrosis of hip and pelvis, unspecified-For	0.003	0.996	0.000
M91.92 Juvenile osteochondrosis of hip and pelvis, unspecified-Upp	0.003	0.996	0.000
M91.91 Juvenile osteochondrosis of hip and pelvis, unspecified-Shl	0.003	0.996	0.000
M91.90 Juvenile osteochondrosis of hip and pelvis, unspecified (Multiple sites)	0.003	0.996	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
M91.19 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Site	0.003	0.997	0.000
M91.18 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Othe	0.003	0.997	0.000
M91.17 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Ankl	0.003	0.997	0.000
M91.16 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Lowe	0.003	0.997	0.000
M91.14 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Hand	0.003	0.997	0.000
M91.13 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Fore	0.003	0.997	0.000
M91.12 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Uppe	0.003	0.997	0.000
M91.11 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Shld	0.003	0.997	0.000
M91.10 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Mult	0.003	0.997	0.000
E23.7 Disorder of pituitary gland, unspecified	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
F33.1 Recurrent depressive disorder, current episode moderate	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
T40.6 Other and unspecified narcotics	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.003	0.997	0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.003	0.997	0.000
M91.15 Juv osteochondrosis head of femur [Legg-Calve-Perthes]-Pelv	0.003	0.997	0.000
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.000	0.997	0.003
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.000	0.997	0.003
M91.29 Coxa plana-Site unspec	0.003	0.997	0.000
M91.28 Coxa plana-Other	0.003	0.997	0.000
M91.27 Coxa plana-Ankle/Foot	0.003	0.997	0.000
M91.26 Coxa plana-Lower Leg	0.003	0.997	0.000
M91.25 Coxa plana-Pelvic/Thigh	0.003	0.997	0.000
M91.24 Coxa plana-Hand	0.003	0.997	0.000
M91.23 Coxa plana-Forearm	0.003	0.997	0.000
M91.22 Coxa plana-Upper arm	0.003	0.997	0.000
M91.21 Coxa plana-Shldr region	0.003	0.997	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.003	0.997	0.000
L94.0 Localised scleroderma [morphea]	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
J32.9 Chronic sinusitis, unspecified	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
E34.9 Endocrine disorder, unspecified	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
R22.2 Localised swelling, mass and lump, trunk	0.003	0.997	0.000
I34.0 Mitral (valve) insufficiency	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
E34 Other endocrine disorders	0.003	0.997	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.003	0.997	0.000
E23.1 Drug-induced hypopituitarism	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
A63.0 Anogenital (venereal) warts	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
F80.1 Expressive language disorder	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
T40.5 Cocaine	0.003	0.997	0.000
C32.1 Supraglottis	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T92 Sequelae of injuries of upper limb	0.000	0.997	0.003
M91.20 Coxa plana-Mult sites	0.002	0.997	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.000	0.997	0.003
E23.6 Other disorders of pituitary gland	0.003	0.997	0.000
R90 Abnormal findings on diagnostic imaging of central nervous system	0.000	0.997	0.003
M05 Seropositive rheumatoid arthritis	0.003	0.997	0.000
N48.4 Impotence of organic origin	0.000	0.997	0.003
M75.4 Impingement syndrome of shoulder	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.997	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.997	0.003
N47 Redundant prepuce, phimosis and paraphimosis	0.003	0.997	0.000
E20-E35 Disorders of other endocrine glands	0.003	0.997	0.000
M05.8 Other seropositive rheumatoid arthritis	0.003	0.997	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.000	0.997	0.003
E23.2 Diabetes insipidus	0.002	0.997	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.997	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.000	0.997	0.003
E34.8 Other specified endocrine disorders	0.002	0.997	0.000
E34.3 Short stature, not elsewhere classified	0.002	0.997	0.000
T40.4 Other synthetic narcotics	0.002	0.997	0.000
T36.0 Penicillins	0.002	0.997	0.000
E24 Cushing's syndrome	0.002	0.997	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.002	0.997	0.000
I34.1 Mitral (valve) prolapse	0.003	0.997	0.000
M13.09 Polyarthritis, unspecified (Site unspecified)	0.002	0.998	0.000
M85.88 Other specified disorders of bone density and structure (Other)	0.002	0.998	0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.002	0.998	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.000	0.998	0.002
E34.5 Androgen resistance syndrome	0.002	0.998	0.000
E34.4 Constitutional tall stature	0.002	0.998	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.002	0.998	0.000
E34.1 Other hypersecretion of intestinal hormones	0.002	0.998	0.000
E24.0 Pituitary-dependent Cushing's disease	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.000	0.998	0.002
E87.6 Hypokalaemia	0.000	0.998	0.002
T42.4 Benzodiazepines	0.002	0.998	0.000
E25 Adrenogenital disorders	0.002	0.998	0.000
T79-T79 Certain early complications of trauma	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
E26 Hyperaldosteronism	0.002	0.998	0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)	0.002	0.998	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.998	0.002
M05.2 Rheumatoid vasculitis	0.002	0.998	0.000
E32 Diseases of thymus	0.002	0.998	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.002	0.998	0.000
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.000	0.998	0.002
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.002	0.998	0.000
M05.1 Rheumatoid lung disease	0.002	0.998	0.000
M05.0 Felty's syndrome	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
M22.4 Chondromalacia patellae	0.000	0.998	0.002
M85.8 Other specified disorders of bone density and structure	0.002	0.998	0.000
E31 Polyglandular dysfunction	0.002	0.998	0.000
E34.0 Carcinoid syndrome	0.002	0.998	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
M05.88 Other seropositive rheumatoid arthritis (Other)	0.002	0.998	0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)	0.002	0.998	0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)	0.002	0.998	0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)	0.002	0.998	0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)	0.002	0.998	0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)	0.002	0.998	0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)	0.002	0.998	0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)	0.002	0.998	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.002	0.998	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.002	0.998	0.000
D47.2 Monoclonal gammopathy	0.002	0.998	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.002	0.998	0.000
E29 Testicular dysfunction	0.002	0.998	0.000
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.002	0.998	0.000
G04.1 Tropical spastic paraplegia	0.002	0.998	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
Z29.0 Isolation	0.002	0.998	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.002	0.998	0.000
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.002	0.998	0.000
E26.9 Hyperaldosteronism, unspecified	0.002	0.998	0.000
G04.0 Acute disseminated encephalitis	0.002	0.998	0.000
G06.1 Intraspinal abscess and granuloma	0.002	0.998	0.000
G03 Meningitis due to other and unspecified causes	0.002	0.998	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.998	0.002
E20 Hypoparathyroidism	0.002	0.998	0.000
M85.83 Other specified disorders of bone density and structure (Forearm)	0.002	0.998	0.000
E22.0 Acromegaly and pituitary gigantism	0.002	0.998	0.000
T92.1 Sequelae of fracture of arm	0.000	0.998	0.002
T92.0 Sequelae of open wound of upper limb	0.000	0.998	0.002
G03.9 Meningitis, unspecified	0.002	0.998	0.000
M85.82 Other specified disorders of bone density and structure (Upper arm)	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
W19.3 Sports and athletics area	0.002	0.998	0.000
F33 Recurrent depressive disorder	0.002	0.998	0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)	0.002	0.998	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.002	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.998	0.002
F80 Specific developmental disorders of speech and language	0.000	0.998	0.002
E25.9 Adrenogenital disorder, unspecified	0.002	0.998	0.000
E25.8 Other adrenogenital disorders	0.002	0.998	0.000
H74.1 Adhesive middle ear disease	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.002	0.998	0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.002	0.998	0.000
E26.8 Other hyperaldosteronism	0.002	0.998	0.000
E26.1 Secondary hyperaldosteronism	0.002	0.998	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
M05.09 Felty's syndrome (Site unspecified)	0.002	0.998	0.000
M05.08 Felty's syndrome (Other)	0.002	0.998	0.000
M05.07 Felty's syndrome (Ankle and foot)	0.002	0.998	0.000
M05.06 Felty's syndrome (Lower leg)	0.002	0.998	0.000
M05.05 Felty's syndrome (Pelvic region and thigh)	0.002	0.998	0.000
M05.04 Felty's syndrome (Hand)	0.002	0.998	0.000
M05.03 Felty's syndrome (Forearm)	0.002	0.998	0.000
M05.02 Felty's syndrome (Upper arm)	0.002	0.998	0.000
M05.01 Felty's syndrome (Shoulder region)	0.002	0.998	0.000
M05.00 Felty's syndrome (Multiple sites)	0.002	0.998	0.000
M05.19 Rheumatoid lung disease (Site unspecified)	0.002	0.998	0.000
M05.18 Rheumatoid lung disease (Other)	0.002	0.998	0.000
M05.17 Rheumatoid lung disease (Ankle and foot)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations